We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Assisted Non-DNA Based Test Identifies Viral Infections in Minutes

By LabMedica International staff writers
Posted on 11 Jun 2025

Confirming viral infections typically involves DNA sequencing tests, which take hours and may not be available on-site. More...

Moreover, these tests cannot differentiate between live and inactive virus particles. Now, a new diagnostic method can rapidly detect viable viruses within minutes, offering a faster and more informative alternative.

The innovative tool was created by researchers at Osaka University (Osaka, Japa) by combining nanopore sensing technology with artificial intelligence (AI) to distinguish viral particles based on their electrical conductivity. This approach eliminates the need for DNA-based testing and can determine if a virus is active, a crucial insight for timely treatment. The system works by pushing individual viral particles through a nanopore and measuring their unique electrical conductivity waveforms. These waveforms are influenced by the particle’s size, surface charge, and molecular structure. The AI model then analyzes these signals to accurately identify the virus, even distinguishing between closely related viruses within the same family.

To evaluate its accuracy, researchers tested the system on herpes viruses that infect the eye, pathogens known to cause blindness if untreated. Fluid samples from the eye’s aqueous humor were analyzed using both traditional PCR and the new AI nanopore method. According to findings published in PNAS Nexus, the AI nanopore method achieved a sensitivity of 100% and a specificity of 71.4%. When conditions were optimized, specificity rose to over 90%. This technology shows strong potential for improving viral diagnostics, particularly in time-sensitive or resource-limited settings. By identifying active infections quickly and without the need for genetic sequencing, the method could help clinicians make faster, more informed treatment decisions—not only for ocular infections but possibly for a wide range of viral diseases.


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
ESR Analyzer
TEST1 2.0
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.